$LGIQ
Logiq Inc

2023 Q3 Form 10-Q Financial Statement

#000157587223001340 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $3.266M $4.861M
YoY Change -20.36% -1.81%
Cost Of Revenue $3.208M $4.331M
YoY Change 14.87% 38.34%
Gross Profit $57.97K $529.9K
YoY Change -95.57% -70.88%
Gross Profit Margin 1.78% 10.9%
Selling, General & Admin $3.257M $3.629M
YoY Change -57.48% -41.57%
% of Gross Profit 5618.1% 684.76%
Research & Development $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 0.0% 0.0%
Depreciation & Amortization $690.0K $420.6K
YoY Change 4926.22% 3499.52%
% of Gross Profit 1190.31% 79.38%
Operating Expenses $3.946M $4.049M
YoY Change -56.17% -51.1%
Operating Profit -$3.888M -$3.519M
YoY Change -49.47% -45.52%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$46.39K -$45.91K
YoY Change -1546466.67% 7787.46%
Pretax Income -$3.930M -$3.565M
YoY Change -48.93% -44.82%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.934M -$3.565M
YoY Change -48.87% -44.82%
Net Earnings / Revenue -120.48% -73.35%
Basic Earnings Per Share -$0.04 -$0.04
Diluted Earnings Per Share -$0.04 -$0.04
COMMON SHARES
Basic Shares Outstanding 103.0M 74.40M
Diluted Shares Outstanding 101.7M 89.35M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $390.0K $489.2K
YoY Change 5.9% 23.41%
Cash & Equivalents $392.9K $489.2K
Short-Term Investments
Other Short-Term Assets $80.00K $282.2K
YoY Change -89.7% -63.6%
Inventory
Prepaid Expenses $84.22K $102.2K
Receivables $600.0K $837.5K
Other Receivables $482.4K $483.9K
Total Short-Term Assets $1.555M $2.093M
YoY Change -62.09% -39.88%
LONG-TERM ASSETS
Property, Plant & Equipment $53.05K $63.42K
YoY Change -53.8% -50.67%
Goodwill $5.578M $5.578M
YoY Change 0.0% 0.0%
Intangibles $5.622M $6.301M
YoY Change -52.16% -50.66%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.25M $11.94M
YoY Change -35.5% -35.36%
TOTAL ASSETS
Total Short-Term Assets $1.555M $2.093M
Total Long-Term Assets $11.25M $11.94M
Total Assets $12.81M $14.04M
YoY Change -40.56% -36.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.944M $3.145M
YoY Change -22.18% 69.57%
Accrued Expenses $2.550M $2.255M
YoY Change -23.72% 17.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.498M $5.399M
YoY Change -24.84% 40.0%
LONG-TERM LIABILITIES
Long-Term Debt $10.00K $10.00K
YoY Change 0.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $10.00K $10.00K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.498M $5.399M
Total Long-Term Liabilities $10.00K $10.00K
Total Liabilities $5.508M $5.409M
YoY Change -24.81% 39.9%
SHAREHOLDERS EQUITY
Retained Earnings -$151.4M -$147.4M
YoY Change 50.78% 59.05%
Common Stock $12.94K $9.585K
YoY Change 251.1% 186.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.300M $8.626M
YoY Change
Total Liabilities & Shareholders Equity $12.81M $14.04M
YoY Change -40.56% -36.08%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$3.934M -$3.565M
YoY Change -48.87% -44.82%
Depreciation, Depletion And Amortization $690.0K $420.6K
YoY Change 4926.22% 3499.52%
Cash From Operating Activities -$2.710M -$3.205M
YoY Change -31.45% -37.99%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $113.5K
YoY Change
Cash From Investing Activities $0.00 $113.5K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.600M 2.829M
YoY Change -33.76% 56.04%
NET CHANGE
Cash From Operating Activities -2.710M -3.205M
Cash From Investing Activities 0.000 113.5K
Cash From Financing Activities 2.600M 2.829M
Net Change In Cash -110.0K -261.8K
YoY Change 291.18% -92.2%
FREE CASH FLOW
Cash From Operating Activities -$2.710M -$3.205M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration
OtherReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001335112
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51815
dei Entity Registrant Name
EntityRegistrantName
LOGIQ INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5057897
dei Entity Address Address Line1
EntityAddressAddressLine1
230 Victoria Street Bugis Junction
dei Entity Address Address Line2
EntityAddressAddressLine2
#15-01/08
dei Entity Address City Or Town
EntityAddressCityOrTown
Singapore
dei Entity Address Country
EntityAddressCountry
SG
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
188024
dei City Area Code
CityAreaCode
65
dei Local Phone Number
LocalPhoneNumber
9366 2322
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
102974814
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6301108
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7119111
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63420
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85430
CY2023Q2 us-gaap Goodwill
Goodwill
5577926
CY2022Q4 us-gaap Goodwill
Goodwill
5577926
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
11942454
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
12782467
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
837461
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
1649632
CY2023Q2 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
0
CY2022Q4 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
58122
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
282244
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
221591
CY2023Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
483921
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
0
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489202
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
472206
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2092828
CY2022Q4 us-gaap Assets Current
AssetsCurrent
2401551
CY2023Q2 us-gaap Assets
Assets
14035282
CY2022Q4 us-gaap Assets
Assets
15184018
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3144656
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5073315
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2254751
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
2169893
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16589
CY2023Q2 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
260220
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5399407
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7520017
CY2023Q2 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000
CY2022Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
10000
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
10000
CY2023Q2 us-gaap Liabilities
Liabilities
5409407
CY2022Q4 us-gaap Liabilities
Liabilities
7530017
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
95848214
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95848214
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55118520
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55118520
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
9585
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5512
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108204431
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
94829417
CY2023Q2 lgiq Capital Reserves
CapitalReserves
47838696
CY2022Q4 lgiq Capital Reserves
CapitalReserves
44232194
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-147426837
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-131413122
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8625875
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7654001
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14035282
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15184018
CY2023Q2 us-gaap Revenues
Revenues
4860561
CY2022Q2 us-gaap Revenues
Revenues
4949976
us-gaap Revenues
Revenues
8398088
us-gaap Revenues
Revenues
13055360
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
4330655
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
3130360
us-gaap Cost Of Revenue
CostOfRevenue
7582899
us-gaap Cost Of Revenue
CostOfRevenue
9031083
CY2023Q2 lgiq Gross Income
GrossIncome
529906
CY2022Q2 lgiq Gross Income
GrossIncome
1819616
lgiq Gross Income
GrossIncome
815189
lgiq Gross Income
GrossIncome
4024277
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
420644
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1030930
us-gaap Depreciation And Amortization
DepreciationAndAmortization
840013
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2061860
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3523857
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5637766
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15688504
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9238763
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
104715
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
572085
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
214715
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
871401
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1039094
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
0
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2296178
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
4049216
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8279875
us-gaap Operating Expenses
OperatingExpenses
16743232
us-gaap Operating Expenses
OperatingExpenses
14468202
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3519310
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6460259
us-gaap Operating Income Loss
OperatingIncomeLoss
-15928043
us-gaap Operating Income Loss
OperatingIncomeLoss
-10443925
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-45905
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-582
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-85672
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2560
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-3565215
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-6460841
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-16013715
us-gaap Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net
IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
-10441365
CY2023Q2 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3565215
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-6460841
us-gaap Net Income Loss
NetIncomeLoss
-16013715
us-gaap Net Income Loss
NetIncomeLoss
-10441365
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0399
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0399
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1981
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1981
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.205
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.205
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3538
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.3538
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89352752
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89352752
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32620160
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32620160
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78099797
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78099797
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29511254
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29511254
us-gaap Net Income Loss
NetIncomeLoss
-16013715
us-gaap Net Income Loss
NetIncomeLoss
-10441365
us-gaap Depreciation
Depreciation
22010
us-gaap Depreciation
Depreciation
25413
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
818003
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2027191
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-812171
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1656839
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60654
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-153261
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-1928659
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-439361
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
84859
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
3864
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
41533
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9795
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16224452
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7023953
lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
0
lgiq Increase Decrease In Amount Due From Associate
IncreaseDecreaseInAmountDueFromAssociate
-7208700
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
483921
us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0
lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
0
lgiq Payments To Acquire Financial Assets Held For Resale
PaymentsToAcquireFinancialAssetsHeldForResale
-681
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-483921
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7209381
lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-260220
lgiq Proceeds From Shares To Be Issueds
ProceedsFromSharesToBeIssueds
-312096
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16985589
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-1043208
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16725369
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1355304
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16996
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1169876
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
472206
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1586265
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
489202
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
416389
lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
12539023
lgiq Issuance Of Shares For Services Received
IssuanceOfSharesForServicesReceived
2326347
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7654001
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
14156150
CY2023Q1 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-12448500
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
9361651
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2829439
CY2023Q2 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-3565215
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
8625875
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29575321
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2784618
CY2022Q1 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
-13
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-3980524
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
22810166
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1741423
CY2022Q2 lgiq Cancellation Of Shares For Proceeds
CancellationOfSharesForProceeds
0
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-6460841
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
18090748
CY2021Q4 lgiq App Logiq Spinoff Description
AppLogiqSpinoffDescription
GoLogiq is a fully reporting U.S. public company. In connection with the Separation, the Company announced that it intended to distribute, on a pro rata basis, 100%
CY2022Q1 lgiq App Logiq Spinoff Description
AppLogiqSpinoffDescription
The Company held the GoLogiq Shares until it distributed 100% of the GoLogiq Shares to the Company’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof will receive 1 share of Lovarra)
lgiq Data Logiq Spinoff Description
DataLogiqSpinoffDescription
At Closing Abri will deliver to the Company $114 million worth of shares Abri common stock, par value $0.0001, at $10.00 per share (the “Merger Consideration Shares”). Also at Closing, the Company will issue a dividend to its shareholders on a pro-rata basis equal to 25% of the aggregate Merger Consideration Shares (the “Dividend Shares”), payable to the Company shareholders of record as of a record date to be set shortly before Closing.
CY2023Q2 us-gaap Tangible Capital Required For Capital Adequacy
TangibleCapitalRequiredForCapitalAdequacy
5000001
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24853721
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17734610
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">USE OF ESTIMATES</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company’s financial statements in conformity with generally accepted accounting principles of the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management makes its best estimate of the ultimate outcome for these items based on historical trends and other information available when the financial statements are prepared. Actual results could differ from those estimates.</div></div>
lgiq Charge For Period For Intangible Assets
ChargeForPeriodForIntangibleAssets
818003
lgiq Operating Segments
OperatingSegments
0.10
CY2023Q2 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
824916
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
2027191
lgiq Operating Lease Rent Expenses Net
OperatingLeaseRentExpensesNet
105000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">ACCOUNTS RECEIVABLE AND CONCENTRATION OF RISK</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Accounts receivable consists of trade receivables from customers. The Company records accounts receivable at its net realizable value, recognizing an allowance for doubtful accounts based on our best estimate of probable credit losses on our existing accounts receivable. Balances are written off against the allowance after all means of collection have been exhausted and the possibility of recovery is considered remote.</div></div>
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24853721
lgiq Additions On Intangible Assets
AdditionsOnIntangibleAssets
0
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18552613
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6301108
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7119111
CY2023Q2 lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
410275
CY2022Q2 lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
1009988
lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
818003
lgiq Amortization Of Intangible Assets Net
AmortizationOfIntangibleAssetsNet
2027191
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
817793
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1636078
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1624478
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
1510945
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
711814
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6301108
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
253362
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
253362
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167932
lgiq Charge For Period
ChargeForPeriod
22010
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
189942
CY2023Q2 lgiq Net Property And Equipment
NetPropertyAndEquipment
63420
CY2022Q4 lgiq Net Property And Equipment
NetPropertyAndEquipment
85430
CY2023Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
10369
CY2022Q2 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
11686
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
22010
us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
25413
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
5577926
CY2022Q4 us-gaap Goodwill Gross
GoodwillGross
5577926
CY2023Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0
CY2023Q2 us-gaap Goodwill
Goodwill
5577926
CY2022Q4 us-gaap Goodwill
Goodwill
5577926
CY2023Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1440211
CY2022Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2252383
CY2023Q2 lgiq Allowance For Doubtful Debts
AllowanceForDoubtfulDebts
602751
CY2022Q4 lgiq Allowance For Doubtful Debts
AllowanceForDoubtfulDebts
602751
CY2023Q2 lgiq Recoveries For Accounts Receivable
RecoveriesForAccountsReceivable
837461
CY2022Q4 lgiq Recoveries For Accounts Receivable
RecoveriesForAccountsReceivable
1649632
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
602751
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155592
lgiq Accounts Receivable Provision For Bad Debts
AccountsReceivableProvisionForBadDebts
0
CY2022 lgiq Accounts Receivable Provision For Bad Debts
AccountsReceivableProvisionForBadDebts
-447159
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
602751
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
602751
CY2023Q2 lgiq Trade Receivables Held For Sales Amount
TradeReceivablesHeldForSalesAmount
837461
CY2023Q2 lgiq Retail Land Sales Receivables Stated Interest Rates
RetailLandSalesReceivablesStatedInterestRates
1
CY2023Q2 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
180000
CY2022Q4 lgiq Deposit And Other Receivable
DepositAndOtherReceivable
180000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
102244
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41591
CY2023Q2 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
282244
CY2022Q4 lgiq Prepayments Deposits And Other Receivables
PrepaymentsDepositsAndOtherReceivables
221591
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2254751
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2169893
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2254751
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2169893
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.21
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.34
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
lgiq Certificate Of Amendment Description
CertificateOfAmendmentDescription
Upon the filing of the Certificate of Amendment, and the resulting effectiveness of the Reverse Stock Split, every 13 outstanding shares of the Company’s Common Stock were, without any further action by the Company, or any holder thereof, combined into and automatically became 1 share of the Company’s Common Stock.
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 lgiq Arithmetic Average Purchase Of Shares Percentage
ArithmeticAveragePurchaseOfSharesPercentage
0.97
CY2022Q1 lgiq Warrants To Purchase Of Common Stock
WarrantsToPurchaseOfCommonStock
631579
CY2022Q1 lgiq Common Stock Percentage
CommonStockPercentage
0.015
CY2022Q1 us-gaap Other Commitment
OtherCommitment
40000000
CY2022Q1 lgiq Ownership Limitation Percentage
OwnershipLimitationPercentage
0.0999
CY2022Q1 us-gaap Stock Issued1
StockIssued1
37000000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
37000000
CY2023Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
132326
CY2022Q4 us-gaap Share Price
SharePrice
0.0001
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
0
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3565215
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6460841
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16013715
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10441365
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89352752
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89352752
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32620160
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32620160
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78099797
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78099797
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29511254
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29511254
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.0399
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.0399
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1981
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.1981
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.205
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.205
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.3538
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3538
CY2021Q3 lgiq Lease Space
LeaseSpace
26954
CY2021Q3 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
26300
CY2021Q4 lgiq Lease Space
LeaseSpace
12422
CY2021Q4 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
17500
lgiq Maturity Date
MaturityDate
2022-12-31
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
4150
CY2023Q2 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
0
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
CY2022Q4 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
58122
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
16589
CY2021 lgiq Operating Lease Lease Payments Present Value Percent
OperatingLeaseLeasePaymentsPresentValuePercent
0.0325
us-gaap Adjustment For Amortization
AdjustmentForAmortization
58122
us-gaap Adjustment For Amortization
AdjustmentForAmortization
102338
lgiq Operating Lease Rent Expenses Net
OperatingLeaseRentExpensesNet
76188
CY2023Q2 lgiq Right To Use Assets Operating Leases
RightToUseAssetsOperatingLeases
0
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2023Q2 lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2022Q2 lgiq Revenues Percentage
RevenuesPercentage
0.10
lgiq Revenues Percentage
RevenuesPercentage
0.10
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4860561
CY2023Q2 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4949976
CY2022Q2 lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
8398088
lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13055360
lgiq Revenue Remaining Performance Of Obligation Percentage
RevenueRemainingPerformanceOfObligationPercentage
1
CY2023Q2 us-gaap Tangible Capital Required For Capital Adequacy
TangibleCapitalRequiredForCapitalAdequacy
5000001

Files In Submission

Name View Source Status
lgiq-20230630_pre.xml Edgar Link unprocessable
0001575872-23-001340-index-headers.html Edgar Link pending
0001575872-23-001340-index.html Edgar Link pending
0001575872-23-001340.txt Edgar Link pending
0001575872-23-001340-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lg012_ex31-1.htm Edgar Link pending
lg012_ex31-2.htm Edgar Link pending
lg012_ex32-1.htm Edgar Link pending
lgiq-20230630.htm Edgar Link pending
lgiq-20230630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lgiq-20230630_def.xml Edgar Link unprocessable
lgiq-20230630_cal.xml Edgar Link unprocessable
lgiq-20230630_lab.xml Edgar Link unprocessable
lgiq-20230630_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending